Emerging Company Profile
Jaguar to deploy $139M series B toward broad gene therapy pipeline
Emerging Company Profile: Jaguar, founded by AveXis vets, raises $139M series B led by Lilly, Deerfield
Jaguar, founded by AveXis vets, is leveraging its team’s experience with Zolgensma and $139M B round to advance gene therapies for indications broader than SMA.
Apr 14, 2021 | 1:42 AM GMT
Less than two months after emerging from stealth, Jaguar raised a $139